Financial Daily from THE HINDU group of publications
Thursday, Oct 16, 2003
News
Features
Stocks
Port Info
Archives

Group Sites

 Corporate - Awards & Honours


Natco gets DSIR award

Our Bureau

HYDERABAD: Natco Pharma Ltd (NPL), the Hyderabad-based pharmaceutical company known for its time-release technology, has been selected for the award of Department of Scientific and Industrial Research (DSIR) for its research and development efforts.

In a press release here on Wednesday, NPL said it was selected for the DSIR National Award for R&D efforts in the industry for 2003 in the drugs and pharmaceutical industries segment.

Article E-Mail :: Comment :: Syndication

Stories in this Section
Kochi Refineries on modernisation path

GNFC plant mishap claims 5 lives
Jai Balaji to float Rs 10-cr IPO
BSES gets 50 offers for power purchase plan
BSES to introduce pre-paid power
Shriram group strikes it rich in Hi-Tech Arai deal
Astec Valve gets Dh1 m orders for `GasFuse' product
Kopran product bags US patent
Caterpillar to increase sourcing from India
Natco gets DSIR award
BSES net jumps to Rs 88.83 cr in Q2
Padmalaya Tele Q2 net up
Micro Labs acquires Dr Reddy's Pondy plant
Bikanervala to set up units in Canada, Dubai
Voltas sets up shop in Dubai
Chinese ceramic co to set up unit in Gujarat
Le Meridien hotels at Ahmedabad, Kovalam, Jaipur soon
Tata group cos exempted from open offer for TFL
Strides signs supply pact with Japanese co
Genome, Shasun in bioinformatics deal
FMCG majors brainstorm to ease supply-chain bottlenecks
Cost management workshop by Kerala-CII
FACT revival: Time running out?
Rival unions clash; Chittivalasa mill locked out again
RSP's new mantra to achieve 100% capacity utilisation
Everest on growth path; plans fresh investments
Alloy Steel's saleable steel output up 15 pc
New Ranbaxy CFO

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line